InnoCare Pharma's (SHA:688428, HKG:9969) net loss attributable to the parent for the first half narrowed year on year to 30.1 million yuan, or 0.02 yuan per share, from 261.8 million yuan, or 0.16 yuan per share, according to a Hong Kong bourse disclosure on Tuesday.

InnoCare's Shanghai shares dropped less than 9%, and Hong Kong shares slumped over 8% during midday trade.

The pharmaceutical company's revenue jumped 74% to 731.4 million yuan from 419.7 million yuan a year earlier, the disclosure said.